Evidence map›Paper›PMID 36909536›Full record

ArticleResearch square2023

Hydroxymethylation alterations in progenitor-like cell types of pediatric central nervous system tumors are associated with cell type-specific transcriptional changes.

Min Kyung Lee, Nasim Azizgolshani, Ze Zhang, Laurent Perreard, Fred W Kolling, Lananh N Nguyen, George J Zanazzi, Lucas A Salas, Brock C Christensen

Open access · greenFull text readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Min Kyung LeeDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.ORCID 0000-0001-9558-4819
Nasim AzizgolshaniDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.ORCID 0000-0002-8663-0251
Ze ZhangDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.ORCID 0000-0001-9854-5823
Laurent PerreardDartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Fred W KollingDartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.ORCID 0000-0002-6178-9901
Lananh N NguyenDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-4276-8934
George J ZanazziDartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.ORCID 0000-0001-9606-9501
Lucas A SalasDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.ORCID 0000-0002-2279-4097
Brock C ChristensenDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.ORCID 0000-0003-3022-426X
Dartmouth College · USColumbia University Irving Medical Center · USUniversity of Toronto · CA

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI MICHAEL L WHITFIELD · 2019 to 2026
$27.2M
Relation Between In-utero Vitamin D and Immune Function in Early Childhood P20GM104416 · NIGMS · DARTMOUTH COLLEGE · PI SALAS DIAZ, LUCAS A · 2013 to 2022
$23.7M
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to ImmunotherapyR01CA253976 · NCI · BROWN UNIVERSITY · PI CHRISTENSEN, BROCK C, KELSEY, KARL TIMOTHY · 2021 to 2025
$3.3M
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomesR01CA216265 · NCI · DARTMOUTH COLLEGE · PI CHRISTENSEN, BROCK CLARKE · 2017 to 2021
$2.9M
Acquisition of the NextSeq2000 Sequencing platform to Increase Next Generation Sequencing Throughput While Reducing Costs at DartmouthS10OD030242 · OD · DARTMOUTH COLLEGE · PI KOLLING IV, FRED W · 2021 to 2021
$321k
10X Genomics Chromium Single-cell Sequencing to Expand Research At DartmouthS10OD025235 · OD · DARTMOUTH COLLEGE · PI TOMLINSON, CRAIG R · 2018 to 2018
$125k
NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA216265NCI NIH HHS R01 CA253976NIGMS NIH HHS P20 GM104416NIGMS NIH HHS P20 GM130454NIH HHS S10 OD025235NIH HHS S10 OD030242Wellcome Trust
6 · The paper itself

Abstract

Although intratumoral heterogeneity has been established in pediatric central nervous system tumors, epigenomic alterations at the cell type level have largely remained unresolved. To identify cell type-specific alterations to cytosine modifications in pediatric central nervous system tumors we utilized a multi-omic approach that integrated bulk DNA cytosine modification data (methylation and hydroxymethylation) with both bulk and single-cell RNA-sequencing data. We demonstrate a large reduction in the scope of significantly differentially modified cytosines in tumors when accounting for tumor cell type composition. In the progenitor-like cell types of tumors, we identified a preponderance differential CpG hydroxymethylation rather than methylation. Genes with differential hydroxymethylation, like

Identifiers

PMID36909536
PMCPMC10002842
OpenAlexW4322623070

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read17
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.